High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.4M
$3,401,509
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Other
|
2026-02-27 | $1,234,700Large | M | Form 4 |
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
10b5-1 SellΔOwn -44.3%
2026-02-27
$978,285
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -44.3%
|
2026-02-27 | $978,285 | S | Form 4 |
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
10b5-1 SellΔOwn -59.4%
2026-02-27
$739,496
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -59.4%
|
2026-02-27 | $739,496 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Other
|
2025-11-12 | $1,234,700Large | M | Form 4 |
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
Discretionary SellΔOwn -77.3%
2025-11-12
$1,683,728Large
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Discretionary SellΔOwn -77.3%
|
2025-11-12 | $1,683,728Large | S | Form 4 |